Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|July 12, 2021
Using Cell Type-Specific Genes to Identify Cell-Type Transitions Between Different <i>in vitro</i> Culture ConditionsXuelin He, Li Liu, Baode Chen, et al.
Therapeutic Advances in Gastroenterology|February 3, 2026
Clinical diagnosis and biomarkers of acute kidney injury in liver cirrhosis: a systematic reviewBaode Chen, Luyan Zheng, Xuelin He, et al.
Frontiers in Immunology|June 20, 2022
The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and TumorigenesisBaode Chen, Chenglin Mu, Zhiwei Zhang, et al.
Frontiers in Psychiatry|April 28, 2022
Clinical Efficacy and Safety of Massage for the Treatment of Restless Leg Syndrome in Hemodialysis Patients: A Meta-Analysis of 5 Randomized Controlled TrialsMin Xia, Qien He, Guanghui Ying, et al.
Scandinavian Journal of Gastroenterology|July 14, 2022
Elevated D-Dimer levels correlate with the development of hepatorenal syndrome and a poor outcome in patients with cirrhosisBaode Chen, Jing Liu, Yongtao Li, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|July 22, 2014
[SPIO-labeled rat bone marrow mesenchymal stem cells: alterations of biological activity and labeling efficiency assay in vitro]Xin Lu, Yongmei Nie, Zhiwei Zhao, et al.
Journal of Diabetes Investigation|November 21, 2024
FOSL2 activates TGF-β1-mediated GLUT1/mTOR signaling to promote diabetic kidney diseaseXuelin He, Min Xia, Guanghui Ying, et al.
Signal Transduction and Targeted Therapy|June 14, 2020
The interactions between cGAS-STING pathway and pathogensZhangliang Cheng, Tong Dai, Xuelin He, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failureXiayu Li, Nan Xu, Heng Li, et al.
JAMA Internal Medicine|April 2, 2014
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysisJun Cheng, Wen Zhang, Xiaohui Zhang, et al.
Pageof 3